Mass.-based Moderna could be first to manufacture bird flu vaccine
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
BioPharma Dive3d
Drugmakers prep for bird flu outbreak, despite continued low risk
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
WGBH2d
What you should know about Massachusetts’ largest-ever outbreak of bird flu
Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...
HealthDay on MSN7d
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
AOL7d
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...
Should we be worried about bird flu, the 'unpredictable shape-shifter'?
Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...
Moderna: The Good News Isn't Enough
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Moderna price target lowered to $50 from $60 at Evercore ISI
Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...